Vaishali Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 228.55 million compared to INR 278 million a year ago. Revenue was INR 245.09 million compared to INR 290.63 million a year ago. Net income was INR 35.05 million compared to INR 22.13 million a year ago. Basic earnings per share from continuing operations was INR 3.32 compared to INR 2.1 a year ago. Diluted earnings per share from continuing operations was INR 3.32 compared to INR 2.1 a year ago.